Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.

PHASE4TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Non-ST Elevation Acute Coronary Syndrome
Interventions
DRUG

ticagrelor

Single loading dose of 180mg of ticagrelor at time of bivalirudin administration. Beginning 12 hrs following study drug administration, all pts in the ticagrelor arm will receive ticagrelor 90 mg (maintenance dose) approximately every 12 hrs until Follow-up telephone contact.

DRUG

clopidogrel

Single loading oral dose of 600 mg of clopidogrel will be given at time of bivalirudin administration. Beginning 4 hrs following study drug administration, all pts in the clopidorgrel arm will receive ticagrelor 180 mg for the loading dose, followed by 90 mg maintenance dose approximately every 12 hours until the Follow-up telephone contact.

Trial Locations (8)

Unknown

Research Site, Jacksonville

Research Site, Lake Mary

Research Site, Macon

Research Site, Oklahoma City

Research Site, Hershey

Research Site, Philadelphia

Research Site, Pittsburgh

Research Site, Rapid City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY